Angeles Alvarez Secord

Researcher Next ID · RN-025968

Researcher · Medicine

Durham, Greece

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Ovarian cancer diagnosis and treatment

Endometrial and Cervical Cancer Treatments

PARP inhibition in cancer therapy

Cancer Genomics and Diagnostics

Intraperitoneal and Appendiceal Malignancies

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1902626
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30029-4
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2017.76.5966
Conservative management of morbidly adherent placenta: expert review
American Journal of Obstetrics and Gynecology · 2015 · https://doi.org/10.1016/j.ajog.2015.04.034
Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer
Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.09.6735
Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer
Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.04.144

No projects listed.